What substances are detected in a positive Urine Toxicology Screen (UTS) or Urine Toxicology Unit (UTU)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Shows in Urinalysis for a Positive Urine Toxicology Screen

A positive urine toxicology screen detects specific drug classes through immunoassay testing, most commonly identifying opiates/opioids, benzodiazepines, amphetamines/methamphetamine, cannabinoids (THC), cocaine metabolites, and phencyclidine (PCP), though many commonly abused substances require specialized testing not included in standard panels. 1

Standard Substances Detected on Routine Panels

Commonly Included Drug Classes

  • Opiates: Standard immunoassays detect morphine and codeine, but do NOT reliably detect synthetic opioids like fentanyl or semisynthetic opioids like oxycodone 1, 2
  • Benzodiazepines: Primarily detect oxazepam (a common metabolite), but frequently miss clonazepam and lorazepam which are not metabolized through the same pathway 2, 3
  • Amphetamines/Methamphetamine: Detect amphetamine-type stimulants, but methylphenidate (Ritalin) is NOT detected on routine amphetamine panels 2, 4
  • Cannabinoids (THC): Detect marijuana metabolites, but synthetic cannabinoids (K2, Spice) will NOT be detected 2
  • Cocaine metabolites: Detect benzoylecgonine, the primary cocaine metabolite 1
  • Phencyclidine (PCP): Included in many standard panels 1

Critical Substances NOT Detected by Standard Testing

Date Rape Drugs and Short-Window Substances

  • Flunitrazepam (Rohypnol): Not identified in routine benzodiazepine tests; detection window only 24 hours in blood and up to 48 hours in urine 2
  • GHB (gamma-hydroxybutyrate): Undetectable in urine after only 12 hours or less 2
  • Ketamine: Variable detection window of 24-72 hours, requires specific testing 2

Commonly Missed Prescription and Illicit Drugs

  • Fentanyl and carfentanil: Not detected by standard opiate immunoassays 2, 4
  • Buprenorphine: Requires specialized testing 4
  • MDMA (Ecstasy): Not detected by standard panels, requires specific testing 2, 4
  • Alcohol: Not included in many standard drug testing panels despite being the most common substance associated with sexual assault 2
  • Inhalants: Not detected by standard tests 2

Understanding Test Methodology and Limitations

Two-Tier Testing Approach

  • Initial screening: Qualitative immunoassay tests (enzyme-linked immunoassay) provide rapid positive/negative results but are susceptible to cross-reactions causing false-positives 1, 3
  • Confirmatory testing: Gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) definitively identifies specific substances and provides quantitative concentrations 1, 3

Detection Windows

  • Most drugs of abuse: 72 hours or less in urine (except marijuana) 2
  • GHB: Less than 12 hours 2
  • Marijuana: Can be detected for weeks in chronic users 2

Common Causes of False-Positive Results

Medications That Cross-React

  • Fluoroquinolone antibiotics: Can cause false-positive opiate results 2
  • Bupropion: Can cause false-positive amphetamine results 4
  • Pseudoephedrine: Most commonly cited cause of false-positive amphetamine screening 4
  • Dextromethorphan: Can cause false-positive results 4
  • Poppy seeds: Cause false-positive morphine and codeine results on both screening AND confirmatory tests 4

Critical Clinical Interpretation Principles

Before Making Clinical Decisions

  • Obtain complete medication history including all prescription medications, over-the-counter drugs, and supplements before interpreting any positive result 4
  • Discuss unexpected results with laboratory personnel or toxicologist before taking action 1, 2
  • Never make punitive decisions based solely on immunoassay results without confirmatory testing 5
  • Request confirmatory GC-MS testing when results are unexpected, inconsistent with clinical picture, or will impact patient management 1, 2, 5

Understanding Metabolite Patterns

  • Hydromorphone is a metabolite of hydrocodone, so positive hydromorphone may not indicate separate use 1
  • Oxymorphone is a metabolite of oxycodone, so positive oxymorphone may reflect prescribed oxycodone 1
  • Morphine can result from prescribed morphine, codeine, or heroin use 5
  • 6-MAM (6-monoacetylmorphine) is the only definitive marker for heroin use, but has a very short detection window 5

Key Pitfalls to Avoid

  • Assuming negative standard test excludes all substance use: Many substances require specialized testing not included in standard panels 2
  • Failing to consider timing of sample collection: Most substances have short detection windows requiring immediate testing if suspected 2
  • Interpreting immunoassay results as definitive: These are screening tests only with known cross-reactivity issues 1, 4
  • Not knowing which specific drugs are included in your laboratory's testing panel: Panels vary by institution and must be understood for proper interpretation 1, 2
  • Testing for substances when results won't affect management: This adds unnecessary costs without clinical benefit 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Limitations of Standard Urine Drug Tests

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Advanced urine toxicology testing.

Journal of addictive diseases, 2010

Guideline

Bupropion and Urine Drug Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urine Drug Testing for Heroin and Morphine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.